Mark A. Velleca - PRESIDENT & CEO, Director at Black Diamond Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT & CEO, Director
Stock Symbol
BDTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark A. Velleca since 4/23/2024

Holdings reported by Mark A. Velleca for Black Diamond Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 122K $304K $2.50 Jan 30, 2025 Direct
Stock Option (Right to Buy) 500K Jan 30, 2025 Direct Common Stock

Transactions reported by Mark A. Velleca for Black Diamond Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.